Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.31
- Piotroski Score 7.00
- Grade Buy
- Symbol (BIOX)
- Company Bioceres Crop Solutions Corp.
- Price $6.45
- Changes Percentage (1.42%)
- Change $0.09
- Day Low $6.35
- Day High $6.57
- Year High $14.05
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. The company also offers HB4, a drought tolerant seed technology program. It operates in Argentina, Uruguay, France, South Africa, and internationally. The company was founded in 2001 and is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/06/2025
- Fiscal Year End N/A
- Average Stock Price Target $13.00
- High Stock Price Target $15.00
- Low Stock Price Target $12.50
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.04
- Trailing P/E Ratio 267
- Forward P/E Ratio 267
- P/E Growth 267
- Net Income $3.24 M
Income Statement
Quarterly
Annual
Latest News of BIOX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights: Strategic Trials and ...
Rescue medications are allowed in the SERENITY study as a safety measure to track inefficacy for patients on placebo. FDA feedback on the TRANQUILITY trial protocol was deemed satisfactory. The compan...
By Yahoo! Finance | 6 days ago -
Bioceres Crop Solutions Corp. (BIOX): Hedge Funds Are Bearish On This Affordable Stock Under $40
An analysis of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) among the worst performing affordable stocks under $40 post-Fed rate cut. The company aims for carbon-neutral farming and showed growth despi...
By Yahoo! Finance | 1 month ago -
Things Look Grim For Bioceres Crop Solutions Corp. (NASDAQ:BIOX) After Today's Downgrade
Analysts have revised Bioceres Crop Solutions Corp.'s forecasts negatively, showing pessimism towards the company's near-term performance. Revenue and earnings estimates were slashed, with a 29% price...
By Yahoo! Finance | 2 months ago
